ev3 plans buy-out of Micro Therapeutics
This article was originally published in Clinica
Executive Summary
ev3, the Plymouth, Minnesota-based developer of endovascular technologies, has proposed to buy all the remaining shares of its partially-owned subsidiary Micro Therapeutics.